| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.18 | 0.04 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |